Skip to main content
Erschienen in: Pituitary 1/2008

01.03.2008

Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency

verfasst von: Gherardo Mazziotti, Antonio Bianchi, Vincenzo Cimino, Stefania Bonadonna, Paola Martini, Alessandra Fusco, Laura De Marinis, Andrea Giustina

Erschienen in: Pituitary | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Growth hormone deficiency (GHD) in adult patients is associated with marked decrease in bone turnover, low bone mass and high risk of clinical and subclinical fractures. We investigated whether the prevalence of spinal deformities in adults with GHD was related to the gonadal status of patients. A total of 89 adult hypopituitary patients with severe GHD were evaluated for bone mineral density (BMD) and vertebral deformities (quantitative morphometric analysis). At the study entry, 54 patients were eugonadic whereas 35 patients were hypogonadic without replacement treatment. Radiological spinal deformities were found in 55 patients (61.8%) with higher prevalence in untreated (56 cases) versus treated (33 cases) GHD patients. Eugonadic and hypogonadic patients showed no significant difference in spinal deformities although T-score was significantly lower in hypogonadic as compared with eugonadic patients. Gonadal function was not correlated with the occurrence of spinal deformities which was instead inversely correlated with rhGH treatment. In conclusion, gonadal status may influence BMD in adult patients with GHD without affecting the risk to develop vertebral deformities. Conversely, rhGH replacement treatment seems to be the only factor influencing the risk to develop vertebral deformities in adult GHD patients.
Literatur
1.
Zurück zum Zitat Ohlsson C, Bengtsson BA, Isaksson OGP, Andreassen TT, Slootweg MC (1998) Growth hormone and bone. Endocr Rev 19:55–79PubMedCrossRef Ohlsson C, Bengtsson BA, Isaksson OGP, Andreassen TT, Slootweg MC (1998) Growth hormone and bone. Endocr Rev 19:55–79PubMedCrossRef
2.
Zurück zum Zitat de Boer H, Block GJ, Van der Veen EA (1995) Clinical aspects of growth hormone deficiency in adults. Endocr Rev 16:63–86PubMedCrossRef de Boer H, Block GJ, Van der Veen EA (1995) Clinical aspects of growth hormone deficiency in adults. Endocr Rev 16:63–86PubMedCrossRef
3.
Zurück zum Zitat Doga M, Bonadonna S, Gola M, Mazziotti G, Giustina A (2006) Growth hormone deficiency in adult. Pituitary 9:305–311PubMedCrossRef Doga M, Bonadonna S, Gola M, Mazziotti G, Giustina A (2006) Growth hormone deficiency in adult. Pituitary 9:305–311PubMedCrossRef
4.
Zurück zum Zitat Wuster C (2000) Fracture rates in patients with growth hormone deficiency. Horm Res 54:31–35PubMedCrossRef Wuster C (2000) Fracture rates in patients with growth hormone deficiency. Horm Res 54:31–35PubMedCrossRef
5.
Zurück zum Zitat Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson BA (1997) Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 137:240–245PubMedCrossRef Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson BA (1997) Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 137:240–245PubMedCrossRef
6.
Zurück zum Zitat Wuster C, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P, KIMS Study Group and the KIMS International Board (2001) Pharmacia & upjohn international metabolic database. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 16:398–405PubMedCrossRef Wuster C, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P, KIMS Study Group and the KIMS International Board (2001) Pharmacia & upjohn international metabolic database. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 16:398–405PubMedCrossRef
7.
Zurück zum Zitat Mazziotti G, Bianchi A, Bonadonna S, Nuzzo M, Cimino V, Fusco A, De Marinis L, Giustina A (2006) Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J Bone Miner Res 21:520–528PubMedCrossRef Mazziotti G, Bianchi A, Bonadonna S, Nuzzo M, Cimino V, Fusco A, De Marinis L, Giustina A (2006) Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J Bone Miner Res 21:520–528PubMedCrossRef
8.
Zurück zum Zitat Doga M, Bonadonna S, Gola M, Mazziotti G, Nuzzo M, Giustina A (2005) GH deficiency in the adult and bone. J Endocrinol Invest 28(8 Suppl):18–23PubMed Doga M, Bonadonna S, Gola M, Mazziotti G, Nuzzo M, Giustina A (2005) GH deficiency in the adult and bone. J Endocrinol Invest 28(8 Suppl):18–23PubMed
9.
Zurück zum Zitat Vandeweghe M, Taelman P, Kaufman JA (1993) Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol 39:409–415 Vandeweghe M, Taelman P, Kaufman JA (1993) Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol 39:409–415
10.
Zurück zum Zitat Kann P, Piepkorn B, Schehler B, Andreas J, Lotz J, Prellwitz W, Beyer J (1998) Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults. Clin Endocrinol 48:561–568CrossRef Kann P, Piepkorn B, Schehler B, Andreas J, Lotz J, Prellwitz W, Beyer J (1998) Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults. Clin Endocrinol 48:561–568CrossRef
11.
Zurück zum Zitat Davidson P, Milne R, Chase D, Cooper C (2004) Growth hormone replacement in adults and bone mineral density: a systematic review and meta-analysis. Clin Endocrinol 60:92–98CrossRef Davidson P, Milne R, Chase D, Cooper C (2004) Growth hormone replacement in adults and bone mineral density: a systematic review and meta-analysis. Clin Endocrinol 60:92–98CrossRef
12.
Zurück zum Zitat Nordin BE, Aaron J, Speed R, Crilly RG (1981) Bone formation and resorption as the determinants of trabecular bone volume in postmenopausal osteoporosis. Lancet 8:277–279CrossRef Nordin BE, Aaron J, Speed R, Crilly RG (1981) Bone formation and resorption as the determinants of trabecular bone volume in postmenopausal osteoporosis. Lancet 8:277–279CrossRef
13.
Zurück zum Zitat Hitz MF, Jensen JE, Eskildsen PC (2006) Bone mineral density in patients with growth hormone deficiency: does a gender difference exist? Clin Endocrinol 65:783–791CrossRef Hitz MF, Jensen JE, Eskildsen PC (2006) Bone mineral density in patients with growth hormone deficiency: does a gender difference exist? Clin Endocrinol 65:783–791CrossRef
14.
Zurück zum Zitat Bengtsson BA, Abs R, Bennmarker H, Monson JP, Feldt-Rasmussen U, Hernberg-Stahl E, Westberg B, Wilton P, Wuster C, KIMS Study Group and the KIMS International Board (1999) The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. J Clin Endocrinol Metab 84:3929–3935PubMedCrossRef Bengtsson BA, Abs R, Bennmarker H, Monson JP, Feldt-Rasmussen U, Hernberg-Stahl E, Westberg B, Wilton P, Wuster C, KIMS Study Group and the KIMS International Board (1999) The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. J Clin Endocrinol Metab 84:3929–3935PubMedCrossRef
15.
Zurück zum Zitat Drake WM, Rodriguez-Arnao J, Weaver JU, James IT, Coyte D, Spector TD, Besser GM, Monson JP (2001) The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study. Clin Endocrinol 54:525–532CrossRef Drake WM, Rodriguez-Arnao J, Weaver JU, James IT, Coyte D, Spector TD, Besser GM, Monson JP (2001) The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study. Clin Endocrinol 54:525–532CrossRef
16.
Zurück zum Zitat Grigoryan M, Guermazi A, Roemer FW, Delmas PD, Genant HK (2003) Recognizing and reporting osteoporotic vertebral fractures. Eur Spine J 12:S104–112PubMedCrossRef Grigoryan M, Guermazi A, Roemer FW, Delmas PD, Genant HK (2003) Recognizing and reporting osteoporotic vertebral fractures. Eur Spine J 12:S104–112PubMedCrossRef
17.
Zurück zum Zitat Reeve J, Lunt M, Felsenberg D, Silman AJ, Scheidt-Nave C, Poor G, Gennari C, Weber K, Lorenc R, Masaryk P, Cannata JB, Dequeker J, Reid DM, Pols HA, Benevolenskaya LI, Stepan JJ, Miazgowski T, Bhalla A, Bruges Armas J, Eastell R, Lopes-Vaz A, Lyritis G, Jajic I, Woolf AD, Banzer D, Reisinger W, Todd CJ, Felsch B, Havelka S, Hoszowski K, Janott J, Johnell O, Raspe HH, Yershova OB, Kanis JA, Armbrecht G, Finn JD, Gowin W, O’Neill TW, European Prospective Osteoporosis Study Group (2003) Determinants of the size of incident vertebral deformities in European men and women in the sixth to ninth decades of age: the European prospective osteoporosis study. J Bone Min Res 18:1664–1673CrossRef Reeve J, Lunt M, Felsenberg D, Silman AJ, Scheidt-Nave C, Poor G, Gennari C, Weber K, Lorenc R, Masaryk P, Cannata JB, Dequeker J, Reid DM, Pols HA, Benevolenskaya LI, Stepan JJ, Miazgowski T, Bhalla A, Bruges Armas J, Eastell R, Lopes-Vaz A, Lyritis G, Jajic I, Woolf AD, Banzer D, Reisinger W, Todd CJ, Felsch B, Havelka S, Hoszowski K, Janott J, Johnell O, Raspe HH, Yershova OB, Kanis JA, Armbrecht G, Finn JD, Gowin W, O’Neill TW, European Prospective Osteoporosis Study Group (2003) Determinants of the size of incident vertebral deformities in European men and women in the sixth to ninth decades of age: the European prospective osteoporosis study. J Bone Min Res 18:1664–1673CrossRef
18.
Zurück zum Zitat Siris ES, Genant HK, Laster AJ, Chen P, Misurski DA, Krege JH (2007) Enhanced prediction of fracture risk combining vertebral fracture status and BMD. Osteoporos Int 18:761–770PubMedCrossRef Siris ES, Genant HK, Laster AJ, Chen P, Misurski DA, Krege JH (2007) Enhanced prediction of fracture risk combining vertebral fracture status and BMD. Osteoporos Int 18:761–770PubMedCrossRef
19.
Zurück zum Zitat Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML (2006) Evaluation and treatment of adult growth hormone deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91:1621–1634PubMedCrossRef Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML (2006) Evaluation and treatment of adult growth hormone deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91:1621–1634PubMedCrossRef
20.
Zurück zum Zitat World Health Organization, Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 1994, 843, Geneva, WHO World Health Organization, Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 1994, 843, Geneva, WHO
21.
Zurück zum Zitat Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D (1997) Guidelines for diagnosis and management of osteoporosis. The european foundation for osteoporosis and bone disease. Osteoporos Int 7:390–406PubMedCrossRef Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D (1997) Guidelines for diagnosis and management of osteoporosis. The european foundation for osteoporosis and bone disease. Osteoporos Int 7:390–406PubMedCrossRef
22.
Zurück zum Zitat Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS, Black D, Cummings SR (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in the osteoporosis. The study of osteoporotic fractures research group. J Bone Min Res 11:984–996CrossRef Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS, Black D, Cummings SR (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in the osteoporosis. The study of osteoporotic fractures research group. J Bone Min Res 11:984–996CrossRef
23.
Zurück zum Zitat Lindsay R, Hart DM, Clark DM (1984) The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 63:759–63PubMed Lindsay R, Hart DM, Clark DM (1984) The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 63:759–63PubMed
24.
Zurück zum Zitat Wronski TJ, Cintron M, Doherty AL, Dann LM (1988) Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123:681–686PubMedCrossRef Wronski TJ, Cintron M, Doherty AL, Dann LM (1988) Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123:681–686PubMedCrossRef
25.
Zurück zum Zitat Kassem M, Okazaki R, Harris SA, Spelsberg TC, Conover CA, Riggs BL (1998) Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor. Calcif Tissue Int 62:60–66PubMedCrossRef Kassem M, Okazaki R, Harris SA, Spelsberg TC, Conover CA, Riggs BL (1998) Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor. Calcif Tissue Int 62:60–66PubMedCrossRef
26.
Zurück zum Zitat Giustina A, Veldhuis JD (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717–797PubMedCrossRef Giustina A, Veldhuis JD (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717–797PubMedCrossRef
27.
Zurück zum Zitat Mazziotti G, Angeli A, Bilezikian JP, Canalis E, Giustina A (2006) Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab 7:144–149CrossRef Mazziotti G, Angeli A, Bilezikian JP, Canalis E, Giustina A (2006) Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab 7:144–149CrossRef
28.
Zurück zum Zitat Khan AA, Hanley DA, Bilezikian JP, Binkley N, Brown JP, Hodsman AB, Josse RG, Kendler DL, Lewiecki EM, Miller PD, Olszynski WP, Petak SM, Syed ZA, Theriault D, Watts NB, Canadian Panel of the International Society for Clinical Densitometry (2006) Standards for performing DXA in individuals with secondary causes of osteoporosis. J Clin Densitom 9:47–57PubMedCrossRef Khan AA, Hanley DA, Bilezikian JP, Binkley N, Brown JP, Hodsman AB, Josse RG, Kendler DL, Lewiecki EM, Miller PD, Olszynski WP, Petak SM, Syed ZA, Theriault D, Watts NB, Canadian Panel of the International Society for Clinical Densitometry (2006) Standards for performing DXA in individuals with secondary causes of osteoporosis. J Clin Densitom 9:47–57PubMedCrossRef
29.
Zurück zum Zitat Cefalu CA (2004) Is bone mineral density predictive of fracture risk reduction? Curr Med Res Opin 20:341–349PubMedCrossRef Cefalu CA (2004) Is bone mineral density predictive of fracture risk reduction? Curr Med Res Opin 20:341–349PubMedCrossRef
30.
Zurück zum Zitat Olesik A, Ott SM, Vedi S, Bravenboer N, Compston J, Lips P (2000) Bone structure in patients with low bone mineral density with or without vertebral fractures. J Bone Min Res 15:1368–1375CrossRef Olesik A, Ott SM, Vedi S, Bravenboer N, Compston J, Lips P (2000) Bone structure in patients with low bone mineral density with or without vertebral fractures. J Bone Min Res 15:1368–1375CrossRef
31.
Zurück zum Zitat Parfitt AM (1992) Implications of architecture for the pathogenesis and prevention of vertebral fracture. Bone 13:S41–44PubMedCrossRef Parfitt AM (1992) Implications of architecture for the pathogenesis and prevention of vertebral fracture. Bone 13:S41–44PubMedCrossRef
32.
Zurück zum Zitat Evans BA, Warner JT, Elford C, Evans SL, Laib A, Bains RK, Gregory JW, Wells T (2003) Morphological determinants of femoral strength in growth hormone-deficient transgenic growth-retarded (Tgr) rats. J Bone Miner Res 18:1308–1316PubMedCrossRef Evans BA, Warner JT, Elford C, Evans SL, Laib A, Bains RK, Gregory JW, Wells T (2003) Morphological determinants of femoral strength in growth hormone-deficient transgenic growth-retarded (Tgr) rats. J Bone Miner Res 18:1308–1316PubMedCrossRef
33.
Zurück zum Zitat Lange M, Qvortrup K, Lander Svendsen O, Flyvbjerg A, Nowak J, Petersen MM, Olgaard K, Feldt-Rasmussen U (2004) Abnormal bone collagen morphology and decreased bone strength in growth hormone-deficient rats. Bone 35:178–185PubMedCrossRef Lange M, Qvortrup K, Lander Svendsen O, Flyvbjerg A, Nowak J, Petersen MM, Olgaard K, Feldt-Rasmussen U (2004) Abnormal bone collagen morphology and decreased bone strength in growth hormone-deficient rats. Bone 35:178–185PubMedCrossRef
Metadaten
Titel
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency
verfasst von
Gherardo Mazziotti
Antonio Bianchi
Vincenzo Cimino
Stefania Bonadonna
Paola Martini
Alessandra Fusco
Laura De Marinis
Andrea Giustina
Publikationsdatum
01.03.2008
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 1/2008
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-007-0069-z

Weitere Artikel der Ausgabe 1/2008

Pituitary 1/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.